Correlation between time to progression and overall survival in patients with metastatic breast cancer

被引：1
|
作者：
Sherrill, B.
Hirst, C.
Wu, Y.
Amonkar, M. M.
Stein, S.
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] RTI Hlth Solut, Manchester, Lancs, England
[3] GlaxoSmithKline Inc, Collegeville, PA USA
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)68914-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A123 / A124
页数：2
相关论文
共 50 条
  • [41] Overall survival outcomes in older patients with metastatic breast cancer: A National Cancer Database analysis
    Patel, Rima
    Kwon, Deukwoo
    Tiersten, Amy
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer
    Chirila, Costel
    Odom, Dawn
    Devercelli, Giovanna
    Khan, Shahnaz
    Sherif, Bintu N.
    Kaye, James A.
    Molnar, Istvan
    Sherrill, Beth
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (05) : 623 - 634
  • [43] Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer
    Costel Chirila
    Dawn Odom
    Giovanna Devercelli
    Shahnaz Khan
    Bintu N. Sherif
    James A. Kaye
    István Molnár
    Beth Sherrill
    International Journal of Colorectal Disease, 2012, 27 : 623 - 634
  • [44] Overall survival in metastatic breast cancer patients according to different follow up strategies for early breast cancer
    Blondeaux, E.
    Boni, L.
    Ruelle, T.
    Di Lauro, V.
    Molinelli, C.
    Piezzo, M.
    Fratini, B.
    Poggio, F.
    Pugliese, P.
    Ferzi, A.
    Buzzatti, G.
    Russo, S.
    Garrone, O.
    Gasparro, S.
    D'Alonzo, A.
    De laurentiis, M.
    Fabi, A.
    Arpino, G.
    Bighin, C.
    Del Mastro, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S497 - S498
  • [45] Surrogacy of progression free survival for overall survival in metastatic breast cancer studies: Meta-analyses of published studies
    Kundu, Madan G.
    Acharyya, Suddhasatta
    CONTEMPORARY CLINICAL TRIALS, 2017, 53 : 20 - 28
  • [46] Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer
    Bauernhofer, T
    Zenahlik, S
    Hofmann, G
    Balic, M
    Resel, M
    Pirchmoser, R
    Regitnig, P
    Ambros, P
    Dandachi, N
    Samonigg, H
    ONCOLOGY REPORTS, 2005, 13 (02) : 179 - 184
  • [47] Relationship between time to trastuzumab initiation and overall survival among young commercially insured women with metastatic breast cancer
    Leopold, Christine
    Zhang, Fang
    Wagner, Anita K.
    Lu, Christine Y.
    Earle, Craig
    Ross-Degnan, Dennis
    Wharam, James Frank
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Exosomal prognostic biomarkers predict metastatic progression and survival in breast cancer patients
    Serdar, Ceyhan Ceran
    Osmanlioglu, Seyma
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2023, 48 (05): : 541 - 562
  • [49] Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study
    La Verde, Nicla
    Collova, Elena
    Blasi, Livio
    Pinotti, Graziella
    Palumbo, Raffaella
    Bonotto, Marta
    Garrone, Ornella
    Brunello, Antonella
    Rimanti, Anita
    Bareggi, Claudia
    Zaniboni, Alberto
    Frassoldati, Antonio
    Foglietta, Jennifer
    Berardi, Rossana
    Moretti, Anna
    Farina, Gabriella
    Porcu, Luca
    Barni, Sandro
    CLINICAL BREAST CANCER, 2021, 21 (05) : E489 - E496
  • [50] Nonhormonal Treatment Regimens Substantially Improve Overall Survival in Patients with Metastatic Breast Cancer
    Bedard, Philippe L.
    Piccart-Gebhart, Martine J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (24): : 1745 - 1747
12345